Atogepant and Migraine
from HeadWise
Atogepant (QULIPTA) was just approved by the FDA as a daily oral preventive treatment for migraine. Can we take gepants like Nurtec or Ubrelvy for our acute migraine attacks if we are taking atogepant? How effective is atogepant and what are the side effects? Does it work as well as the injected monoclonal antibodies for migraine prevention? On this episode, Lindsay Weitzel, PhD, asks migraine clinical trial expert Tim Smith, MD, all the hard questions.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of HeadWise?
This episode is 21 minutes long.
When was this HeadWise episode published?
This episode was published on October 13, 2021.
Can I download this HeadWise episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.